Heart HealthOne Month of Dual Therapy Then Blood Thinner Alone Looks Feasible After Stenting in High-Bleeding-Risk Patients
Many older heart patients who get a coronary stent also take a blood thinner for another condition, such as atrial fibrillation. They are often at high risk of bleeding, so doctors want to cut the number of drugs they take as early as possible. This sub-analysis of the POEM trial looked at 439 high-bleeding-risk patients who received a bioresorbable-polymer drug-eluting stent. Patients without a blood-thinner need (281) took two antiplatelet drugs for one month, then one. Patients who needed an anticoagulant (158) took it with one antiplatelet drug for one month, then the anticoagulant alone. At one year, the combined rate of cardiac death, heart attack or stent clot was 2.6% in the anticoagulant group and 6.1% in the other group, a difference that was not statistically significant. Serious bleeding was uncommon in both groups (1.3% vs 2.6%). The groups were not randomized against each other, so this supports further testing rather than a change in practice.